Dennis Henriksen

Dennis Henriksen is an accomplished executive with extensive experience in the life sciences sector. Currently serving as the Chief Executive Officer of Cenexum, Henriksen focuses on developing innovative implantable devices for bio-inspired data processing and neurostimulation. As Chief Technology Officer at WntResearch AB and former Chief Technology Officer at Idogen AB, Henriksen contributed to significant advancements in treatment strategies for autoimmune diseases and transplant rejection. As a Managing Partner at DBH BION, Henriksen offers expert management consulting for biotech and pharmaceutical firms. Previous leadership roles include CEO of Sanos Bioscience and VP of R&D at Nordic Bioscience, where Henriksen oversaw a range of projects from R&D to clinical development. Henriksen holds a Ph.D. in Bioorganic Chemistry from the University of Copenhagen and an M.Sc. in Chemical Engineering from The Technical University.